2472
G. A. Heropoulos et al. / Tetrahedron Letters 46 (2005) 2469–2473
2.20 (m, 2H, CH), 2.91 (m, 2H, CH), 7.08 (s, 1H, CH);
13C NMR (75 MHz, CDCl3): d 12.0, 12.9, 28.1, 29.0,
42.3, 45.8, 126.9, 129.7, 144.2, 156.3;HR-MS (EI) m/z
calcd for C26H45NO2: 403.3450. Found 403.3446;IR
(cmꢀ1) 1526 (vs), 1381 (vs).
3.13. 2,3,5,6-Tetra(1-ethylpropyl)phenylamine, 7c
Mp 70 ꢁC; 1H NMR (300 MHz, CDCl3) d 0.78 (t,
J = 7.3 Hz, 12H, CH3), 0.87 (t, J = 7.3 Hz, 12H, CH3),
1.58 (m, 8H, CH2), 1.79 (m, 8H, CH2), 2.79 (m, 2H,
CH), 3.00 (m, 2H, CH), 3.47 (s, 2H, NH2), 6.38 (s,
1H, CH); 13C NMR (75 MHz, CDCl3): d 12.0, 13.4,
26.2, 28.8, 41.1, 42.7, 125.3, 141.5, 143.6;HR-MS (EI)
m/z calcd for C26H47N: 373.3708. Found 373.3703;IR
(cmꢀ1) 3500 (m), 3424 (w).
3.8. 4-(1-Ethylpropyl)phenylamine, 1c
1H NMR (300 MHz, CDCl3) d 0.87 (t, J = 7.3 Hz,
3H, CH3), 0.88 (t, J = 7.3 Hz, 3H, CH3), 1.59 (m, 2H,
CH2), 1.72 (m, 2H, CH2), 2.28 (m, 1H, CH), 3.59 (s,
2H, NH2), 6.71 (d, J = 7.2 Hz, 2H, CH), 7.00 (d,
J = 7.2 Hz, 2H, CH); 13C NMR (75 MHz, CDCl3): d
12.3, 29.5, 48.9, 115.3, 128.6, 135.9, 144.3;HR-MS
(EI) m/z calcd for C11H17N: 163.1361. Found
163.1359;IR (cm ꢀ1) 3440 (m), 3354 (m), 3219 (w).
Acknowledgments
This work was supported by the Greek General Secre-
tariat of Research and Technology. We would like to
thank Dr. A. Nikolopoulos for advice and assistance
in setting up the ultrasonic apparatus.
3.9. 3,4-Di(1-ethylpropyl)phenylamine, 2c
1H NMR (300 MHz, CDCl3) d 0.83 (m, 12H, CH3), 1.53
(m, 4H, CH2), 1.65 (m, 4H, CH2), 2.74 (m, 2H, CH),
3.45 (br s, 2H, NH2), 6.52 (m, 2H, CH), 6.95 (m, 1H,
CH); 13C NMR (75 MHz, CDCl3): d 12.3, 29.2, 41.4,
41.9, 112.6, 113.2, 126.6, 134.6, 143.6, 145.2;HR-MS
(EI) m/z calcd for C16H27N: 233.2143. Found
233.2140;IR (cm ꢀ1) 3450 (m), 3359 (m), 3219 (w).
References and notes
1. Tokitoh, N.;Okazaki, R. Coord. Chem. Rev. 2000, 210,
251–277;Power, P. P. Chem. Commun. 2003, 2091–2101;
Toyota, K.;Kawasaki, S.;Yoshifuji, M. J. Org. Chem.
2004, 69, 5065–5070;Weidenbruch, M. Organometallics
2003, 22, 4348–4360;Kobayashi, K.;Takagi, N.;Nagase,
S. Organometallics 2001, 20, 234–236;Dutan, C.;Shah, S.;
Smith, R. C.;Choua, S.;Berclaz, T.;Geoffroy, M.;
Protasiewicz, J. D. Inorg. Chem. 2003, 42, 6241–6251;Hu,
Y. H.;Su, M. D. Chem. Phys. Lett. 2003, 378, 289–298.
2. Catsoulacos, D. P.;Steele, B. R.;Heropoulos, G. A.;
Micha-Screttas, M.;Screttas, C. G. Tetrahedron Lett.
2003, 44, 4575–4578;Connor, E. F.;Younkin, T. R.;
Henderson, J. I.;Waltman, A. W.;Grubbs, R. H. Chem.
Commun. 2003, 2272–2273;Gonsalvi, L.;Gaunt, J. A.;
Adams, H.;Castro, A.;Sunley, G. J.;Haynes, A.
Organometallics 2003, 22, 1047–1054;Dove, A. P.;Gib-
son, V. C.;Hormnirun, P.;Marshall, E. L.;Segal, J. A.;
White, A. J. P.;Williams, D. J. Dalton Trans. 2003, 3088–
3097;Jenkins, J. C.;Brookhart, M. J. Am. Chem. Soc.
2004, 126, 5827–5842;Roder, J. C.;Meyer, F.;Kaifer, E.;
Pritzkow, H. Eur. J. Inorg. Chem. 2004, 1646–1660;
Krajete, A.;Steiner, G.;Kopacka, H.;Ongania, H. K.;
Wurst, K.;Kristen, M. O.;Preishuber-Pflugl, P.;Bildstein,
B. Eur. J. Inorg. Chem. 2004, 1740–1752;Axenov, K. V.;
Kotov, V. V.;Klinga, M.;Leskela, M.;Repo, T. Eur. J.
Inorg. Chem. 2004, 695–706;van der Vlugt, J. T.;Hewat,
A. C.;Neto, S.;Sablong, R.;Mills, A. M.;Lutz, M.;Spek,
A. L.;Muller, C.;Vogt, D. Adv. Synth. Catal. 2004, 346,
993–1003.
3. Groysman, S.;Segal, S.;Goldberg, I.;Kol, M.;Goldsch-
midt, Z. Inorg. Chem. Commun. 2004, 7, 938–941;Ham-
ilton, C. W.;Laitar, D. S.;Sadighi, J. P. Chem. Commun.
2004, 1628–1629;Roder, J. C.;Meyer, F.;Kaifer, E.;
Pritzkow, H. Eur. J. Inorg. Chem. 2004, 1646–1660;
Volꢁeva, V. B.;Karmilov, A. Y.;Belostotskaya, I. S.;
Komissarova, N. L.;Prokof ꢁev, A. I. Polym. Sci. A 2004,
46, 264–269;Shivanyuk, A.;Saadioui, M.;Broda, F.;
Thondorf, I.;Vysotsky, M. O.;Rissanen, K.;Kolehmai-
nen, E.;Bohmer, V. Chem. Eur. J. 2004, 10, 2138–2148.
4. Siraki, A. G.;Chan, T. S.;O ꢁBrien, P. J. Toxicol. Sci.
2004, 81, 148–159;Seifert, S.;Kunstler, J. U.;Schiller, E.;
Pietzsch, H. J.;Pawelke, B.;Bergmann, R.;Spies, H.
Bioconjugate Chem. 2004, 15, 856–863;Durand, G.;
Polidori, A.;Ouari, O.;Tordo, P.;Geromel, V.;Rustin,
P.;Pucci, B. J. Med. Chem. 2003, 46, 5230–5237;Kara-
3.10. 2,4-Di(1-ethylpropyl)phenylamine, 3c
1H NMR (300 MHz, CDCl3) d 0.82 (m, 12H, CH3), 1.6
(m, 8H, CH2), 2.16 (m, 1H, CH), 2.49 (m, 1H, CH),
3.07 (br s, 2H, NH2), 6.65 (d, J = 7.5 Hz, 1H, CH),
6.76 (d, J = 7.5 Hz, 1H, CH), 7.04 (d, J = 7.5 Hz, 1H,
CH); 13C NMR (75 MHz, CDCl3): d 11.9, 12.2, 27.6,
29.2, 41.9, 49.0, 123.1, 126.5, 129.5, 136.1, 142.1,
146.4;HR-MS (EI) m/z calcd for C16H27N: 233.2143.
Found 233.2138;IR (cm ꢀ1) 3465 (m), 3374 (m), 3219
(w).
3.11. 2,5-Di(1-ethylpropyl)phenylamine, 4c
1H NMR (300 MHz, CDCl3) d 0.83 (t, J = 7.3 Hz, 6H,
CH3), 0.87 (t, J = 7.3 Hz, 6H, CH3), 1.69 (m, 8H,
CH2), 2.22 (m, 1H, CH), 2.47 (m, 1H, CH), 3.65 (br s,
2H, NH2), 6.49 (s, 1H, CH), 6.60 (d, J = 7.7 Hz, 1H,
CH), 6.98 (d, J = 7.7 Hz, 1H, CH); 13C NMR
(75 MHz, CDCl3): d 12.0, 12.3, 27.9, 29.3, 41.8, 49.4,
115.6, 118.8, 126.5, 127.4, 143.8, 144.0;HR-MS (EI)
m/z calcd for C16H27N: 233.2143. Found 233.2139;IR
(cmꢀ1) 3470 (m), 3379 (m), 3219 (w).
3.12. 2,4,6-Tri(1-ethylpropyl)phenylamine, 5c
1H NMR (300 MHz, CDCl3) d 0.73 (t, J = 7.3 Hz, 6H,
CH3), 0.81 (t, J = 7.3 Hz, 12H, CH3), 1.61 (m, 12H,
CH2), 2.16 (m, 1H, CH), 2.50 (m, 2H, CH), 3.39 (br s,
2H, NH2) 6.61 (s, 2H, CH); 13C NMR (75 MHz,
CDCl3): d 11.8, 12.1, 27.8, 42.2, 49.2, 123.3, 129.6,
135.1, 139.9;HR-MS (EI) m/z calcd for C21H37N:
303.2926. Found 303.2922;IR (cm ꢀ1) 3480 (m), 3394
(w), 3219 (vw).